| Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies P Navarro, Á Arias, L Arias‐González, EJ Laserna‐Mendieta, ... Alimentary pharmacology & therapeutics 49 (9), 1116-1125, 2019 | 234 | 2019 |
| Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease FJ Ryan, AM Ahern, RS Fitzgerald, EJ Laserna-Mendieta, EM Power, ... Nature communications 11 (1), 1512, 2020 | 206 | 2020 |
| A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors AG Clooney, CN Bernstein, WD Leslie, K Vagianos, M Sargent, ... Alimentary pharmacology & therapeutics 43 (9), 974-984, 2016 | 172 | 2016 |
| Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study AG Clooney, J Eckenberger, E Laserna-Mendieta, KA Sexton, ... Gut 70 (3), 499-510, 2021 | 165 | 2021 |
| Determinants of reduced genetic capacity for butyrate synthesis by the gut microbiome in Crohn’s disease and ulcerative colitis EJ Laserna-Mendieta, AG Clooney, JF Carretero-Gomez, C Moran, ... Journal of Crohn's and Colitis 12 (2), 204-216, 2018 | 93 | 2018 |
| Piphillin predicts metagenomic composition and dynamics from DADA2-corrected 16S rDNA sequences NR Narayan, T Weinmaier, EJ Laserna-Mendieta, MJ Claesson, ... BMC genomics 21, 1-12, 2020 | 81 | 2020 |
| Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry EJ Laserna‐Mendieta, S Casabona, D Guagnozzi, E Savarino, A Perelló, ... Alimentary pharmacology & therapeutics 52 (5), 798-807, 2020 | 77 | 2020 |
| Efficacy of therapy for eosinophilic esophagitis in real-world practice EJ Laserna-Mendieta, S Casabona, E Savarino, A Perelló, ... Clinical Gastroenterology and Hepatology 18 (13), 2903-2911. e4, 2020 | 64 | 2020 |
| Biological variation and reference change values of common clinical chemistry and haematologic laboratory analytes in the elderly population D Pineda-Tenor, EJ Laserna-Mendieta, J Timón-Zapata, ... Clinical Chemistry and Laboratory Medicine (CCLM) 51 (4), 851-862, 2013 | 58 | 2013 |
| Poder diagnóstico y pronóstico de los biomarcadores para mejorar el manejo de la neumonía adquirida en la comunidad en los servicios de urgencias A Julián-Jiménez, JT Zapata, EJL Mendieta, I Sicilia-Bravo, ... Enfermedades infecciosas y microbiologia clinica 32 (4), 225-235, 2014 | 48* | 2014 |
| Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis P Navarro, EJ Laserna-Mendieta, D Guagnozzi, S Casabona, A Perelló, ... Digestive and Liver Disease 53 (11), 1479-1485, 2021 | 36 | 2021 |
| Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations EJ Laserna-Mendieta, AJ Lucendo Clinical Chemistry and Laboratory Medicine (CCLM) 57 (9), 1295-1307, 2019 | 34 | 2019 |
| Capacidad de la procalcitonina para predecir bacteriemia en pacientes con neumonía adquirida en la comunidad A Julián-Jiménez, JT Zapata, EJL Mendieta, RP Miguez, MF Chacartegui, ... Medicina Clínica 142 (7), 285-292, 2014 | 33* | 2014 |
| Esophageal perforation in eosinophilic esophagitis: a systematic review on clinical presentation, management and outcomes L Arias-Gonzalez, E Rey-Iborra, M Ruiz-Ponce, EJ Laserna-Mendieta, ... Digestive and Liver Disease 52 (3), 245-252, 2020 | 31 | 2020 |
| Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies EJ Laserna-Mendieta, JA FitzGerald, L Arias-Gonzalez, JM Ollala, ... Scientific Reports 11 (1), 7113, 2021 | 30 | 2021 |
| Proteomic analysis of phosphorylated nuclear proteins underscores novel roles for rapid actions of retinoic acid in the regulation of mRNA splicing and translation EJ Laserna, ML Valero, L Sanz, MM Sanchez del Pino, JJ Calvete, ... Molecular endocrinology 23 (11), 1799-1814, 2009 | 27 | 2009 |
| Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease S Salvador-Martín, B López-Cauce, O Nuñez, EJ Laserna-Mendieta, ... Pharmacological research 149, 104478, 2019 | 23 | 2019 |
| Accurate and timely diagnosis of Eosinophilic Esophagitis improves over time in Europe. An analysis of the EoE CONNECT Registry P Navarro, EJ Laserna‐Mendieta, S Casabona, E Savarino, ... United European gastroenterology journal 10 (5), 507-517, 2022 | 22 | 2022 |
| Extreme concentrations of high density lipoprotein cholesterol affect the calculation of low density lipoprotein cholesterol in the Friedewald formula and other proposed formulas J Timón-Zapata, EJ Laserna-Mendieta, D Pineda-Tenor, ... Clinical biochemistry 44 (17-18), 1451-1456, 2011 | 21 | 2011 |
| Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits EJ Laserna-Mendieta, S Salvador-Martín, L Arias-González, ... Clinical Chemistry and Laboratory Medicine (CCLM) 57 (12), 1906-1914, 2019 | 19 | 2019 |
Alfredo J Lucendo (ORCID:0000-0003...Sección de Aparato Digestivo. Hospital General de Tomelloso. Servicio de Salud de Castilla La ManchaVerified email at sescam.jccm.es
